PFT:PA:PA-Invesco FTSE RAFI US 1000 UCITS ETF EUR (EUR)

ETF | Others |

Last Closing

USD 33.59

Change

+0.02 (+0.04)%

Market Cap

USD 0.46B

Volume

138.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-10 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

N/A

USD 55.36B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+3.50 (+0.60%)

USD 14.29B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+1.55 (+0.37%)

USD 13.82B
WRD:PA HSBC MSCI World UCITS ETF

+0.23 (+0.63%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+1.48 (+0.58%)

USD 9.11B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+5.00 (+0.98%)

USD 8.92B
WLD:PA Lyxor UCITS MSCI World D-EUR

+2.01 (+0.55%)

USD 7.99B
HHH:PA HSBC S&P 500 UCITS ETF

+0.28 (+0.48%)

USD 7.71B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.12 (+0.59%)

USD 6.91B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+0.91 (+0.55%)

USD 5.17B

ETFs Containing PFT:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.69% 63% D 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.69% 63% D 61% D-
Trailing 12 Months  
Capital Gain 20.33% 73% C 79% B-
Dividend Return 1.66% 23% F 22% F
Total Return 21.98% 76% C+ 79% B-
Trailing 5 Years  
Capital Gain 70.82% 82% B 84% B
Dividend Return 9.86% 41% F 39% F
Total Return 80.68% 87% B+ 86% B+
Average Annual (5 Year Horizon)  
Capital Gain 17.18% 85% B 81% B-
Dividend Return N/A 66% D+ 95% A
Total Return N/A 57% F 13% F
Risk Return Profile  
Volatility (Standard Deviation) N/A 90% A- 98% N/A
Risk Adjusted Return N/A 98% N/A 84% B
Market Capitalization 0.46B 63% D 67% D+

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike